The power of the protocol
- 1 November 2002
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 360 (9346) , 1620-1622
- https://doi.org/10.1016/s0140-6736(02)11652-7
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Seminal pharmaceutical trials: maintaining masking in analysisThe Lancet, 2002
- Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?BMJ, 2002
- The Clinical TrialControlled Clinical Trials, 2001
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Reporting standards and research strategies for controlled trialsControlled Clinical Trials, 1980